Drug
Levonorgestrel Ius
Levonorgestrel Ius: highest development phase Post-Market, developed by Bayer. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Bayer
Trials
| Drug | Phase | Indication |
|---|---|---|
| levonorgestrel IUS NCT02362373 | Post-Market | Epilepsy |
Latest
No recent events.
Follow Levonorgestrel Ius on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.